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Abstract 
Although a clearer understanding of the underlying mechanisms involved in protection and 
immunopathology during blood-stage malaria has emerged, the mechanisms involved in reg-
ulating the adaptive immune response especially those required to maintain a balance between 
beneficial  and  deleterious  responses  remain  unclear.  Recent  evidence  suggests  the  im-
portance of CD11c
+ dendritic cells (DC) and CD4
+Foxp3
+ regulatory T cells in regulating 
immune responses during infection and autoimmune disease, but information concerning the 
contribution of these cells to regulating immunity to malaria is limited. Here, we review recent 
findings from our laboratory and others in experimental models of malaria in mice and in 
Plasmodium-infected humans on the roles of DC and natural regulatory T cells in regulating 
adaptive immunity to blood-stage malaria. 
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Introduction 
As a result of a massive scale-up in malaria con-
trol programs by the WHO as part of the Millennium 
Development  Goals,  the  number  of  malaria  deaths 
decreased worldwide by about 20% between 2000 and 
2009 (1). Although this represents some progress in 
reducing  the  disease  burden,  malaria  nevertheless 
remains a major global health threat and continues to 
cause  high  morbidity  and  mortality,  especially  in 
sub-Saharan Africa where almost 600 million people 
are at risk. Malaria persists due to the lack of an effi-
cacious vaccine, the spread of drug-resistant parasites, 
and  the  emergence  of  insecticide-resistant  Anopheles 
mosquito  vectors  as  well  as  changing  agricultural 
practices,  global  warming,  and  human  migration 
(2,3).  Refugees  exposed  to  malaria  and  other  infec-
tious diseases in their country of origin or in camps 
who  immigrate  to  developed  countries  may  be  im-
portant  reservoirs  and  further  hasten  the  spread  of 
malaria to other regions (4-6). Of the Plasmodium par-
asites (P. falciparum, P. vivax, P. malariae, P. ovale curtisi, 
P. ovale wallikeri,  and  P. knowlesi)  that  cause  human 
malaria, P. falciparum is the most virulent and deadly 
parasite (7, 8). Most deaths due to P. falciparum infec-
tion  occur  in  sub-Saharan  Africa,  with  92%  of  the 
annual malaria deaths occurring among infants and 
young children <5 years of age (1,9-11). In this region, 
these  individuals  and  pregnant  women,  especially 
primigravidae, are the groups with the highest risk for 
the development of severe and fatal complications of 
P.  falciparum  infection  especially  cerebral  malaria 
(CM)  and  severe  malarial  anemia  (SMA),  (2,9-11). 
Unprotected  travelers  and  other  non-immune  indi-
viduals are also extremely vulnerable to these com-
plications.  
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Immunity to infection with blood-stage Plasmo-
dium parasites is critically dependent  on the type 1 
cytokine  IFN-  and  requires  coordinate  and  timely 
innate  and  adaptive  immune  responses  involving 
dendritic cells (DC), NK cells, CD4+ T helper cells, and 
B  cells  (12,13).  Importantly,  a  balance  between 
pro-inflammatory and anti-inflammatory responses is 
essential to limit the development of life-threatening 
immune-mediated pathology such as CM and SMA 
(14). Although a clearer understanding of the mecha-
nisms  involved  in  protective  immunity  and  im-
munopathology  is  emerging,  our  understanding  of 
the regulatory mechanisms required to maintain the 
balance between beneficial and deleterious responses 
during blood-stage malaria infection remains limited. 
Here, we review recent findings from our laboratory 
and others in experimental models of malaria in mice 
and in Plasmodium-infected humans on the activation 
and expansion of CD11c+ DC and Foxp3+ regulatory T 
cells and their possible roles in regulating adaptive 
immunity to blood-stage malaria. 
Life cycle of the Plasmodium parasite and 
pathogenesis 
The life cycle of the malaria parasite is complex 
with a sexual phase in the Anopheles mosquito vector 
and an asexual phase in the host (12). Sporozoites are 
transmitted to the host by the bite of an infected fe-
male mosquito and travel via the blood to the liver 
where  they  invade  hepatocytes  and  initiate  the 
exo-erythrocytic or liver stage, which is clinically si-
lent  and  without  any  pathologic  sequelae.  Parasite 
multiplication in the liver results in merozoites that 
infect red blood cells (RBC), where they undergo mi-
tosis and form erythrocytic schizonts containing many 
merozoites that are released and infect new RBC. As 
yet unknown factors trigger some merozoites to dif-
ferentiate into male and female gametocytes that are 
taken-up  during  a  blood  meal  by  the  mosquito  for 
fertilization and sporozoite production (15). The ma-
jor manifestations of malaria in infected individuals 
include fever, malaise, splenomegaly, and anemia and 
are due to the cyclical multiplication of merozoites in 
RBC (12,14). During P. falciparum infection, the spec-
trum of severe pathology is broad and includes met-
abolic  acidosis,  CM,  and  SMA,  and  is  typically  ac-
companied by hypoxia, hypoglycemia, and lactic ac-
idosis due in part to the increased metabolic demands 
of the parasite (12,14). 
Mouse malaria models 
Human malaria is due to infection with 6 Plas-
modium parasites. P. falciparum, the most virulent and 
deadly  human  parasite,  is  highly  prevalent  in 
sub-Saharan Africa (1). P. vivax is the most common 
species  causing  human  infection  and  predominates 
outside Africa in South America and Asia while in-
fections with  P. malariae and P. ovale subspecies are 
usually  mild.  Recently,  human  infections  with  P. 
knowlesi, a parasite naturally occurring among mon-
keys, have been identified in malaria endemic areas 
(8). Numerous challenges such as the lack of access to 
appropriate  tissue  samples  and  the  inability  to  ma-
nipulate the immune response to elucidate underly-
ing mechanisms impede the study of malaria in hu-
mans (16). As an alternative, experimental models in 
non-human  primates  and  rodent  models  have  been 
used. However, the lack of availability and high cost 
as well as ethical issues limit the use of non-human 
primates  to  study  malaria.  Infection  of  inbred  mice 
with various rodent Plasmodium species (P. chabaudi, 
P. berghei, P. vinckei and P. yoelii) that differ in viru-
lence  and  pathology  provide  the  most  convenient 
experimental models (Table 1) (12,17). It is important 
to note that while no single rodent model replicates all 
of the features of human malaria in terms of patho-
physiology or immune responses, these models have 
been  essential  in  defining  the  basis  of  interactions 
between the host and the Plasmodium parasite. Studies 
in  mouse  malaria  models  have  revealed  important 
and  novel  information  leading  to  a  clearer  under-
standing of the immune response in protection and 
pathogenesis,  to  identify  previously  unrecognized 
genes that regulate susceptibility to malaria, and to 
develop malaria vaccines and novel chemotherapeu-
tic agents (12,17-21). 
 
Table 1. Rodent malaria parasites and their pathogenesis 
P. chabaudi AS 
 
Malarial anemia 
 
P. berghei ANKA 
 
Cerebral malaria 
 
P. vinckei 
 
Hyperparasitemia 
 
P. yoelii 17XL 
 
Hyperparasitemia 
 
 
 
Because  P.  chabaudi  AS  is  considered  to  share 
many  biological  and  immunological  features  in 
common with P. falciparum, infection of mice with this 
parasite  is  widely  used  as  a  tool  to  study  immune 
responses to blood-stage malaria (12,17,19). Infection 
of resistant C57BL/6 (B6) mice with 104-106 P. chabaudi 
AS infected RBC (iRBC) results in a course of para-
sitemia  characterized  by  parasite  replication  during 
the  first  week  post  infection  (p.i.)  culminating  in  a 
moderate peak parasitemia of 30-35% between days Int. J. Biol. Sci. 2011, 7 
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8-10 p.i., with control of parasitemia and clearance by 
about 4 weeks p.i. (12,17,19). In a seminal study, Grun 
and Weidanz demonstrated in mice infected with P. 
chabaudi  that:  1)  the  control  of  peak  parasitemia  is 
dependent on a cell-mediated immune response that 
we now know requires CD4+ T cells, and 2) the re-
quirement for B cells in the clearance and elimination 
of the parasite (12). Later studies from our laboratory 
showed that control of acute P. chabaudi AS infection 
is  critically  dependent  on  IL-12-dependent  IFN- 
production by NK cells and CD4+ Th1 cells indicating 
the importance of both innate and adaptive immune 
responses (12). The importance of cognate interactions 
between CD4+ Th cells and B cells for malaria-specific 
antibody production for efficient parasite elimination 
later  during  infection  was  demonstrated  by  Lang-
horne and her colleagues (12,17). Identification of the 
importance of NK cells, CD4+ T cells, and B cells in 
mediating  control  and  resolution  of  P.  chabaudi  AS 
infection has provided a framework to delineate the 
accessory cells and cytokines involved  in activating 
innate immunity and triggering adaptive immunity to 
malaria. Studies in mice infected with avirulent and 
virulent strains of P. yoelii as well as in mice infected 
with P. berghei ANKA have also provided important 
information about the role of the immune response in 
protection and immunopathogenesis (14,17,21). 
Dendritic cells and blood-stage malaria 
DC are a heterogeneous and highly specialized 
population  of  antigen  presenting  cells  (APC)  that 
provide a central link between innate and adaptive 
immune responses and play an important role at the 
host-pathogen  interface  including  in  response  to 
Plasmodium parasites (22-25). DC reside in almost all 
tissues  where  they  play  important  roles  in  surveil-
lance and sensing foreign antigens. Pattern recogni-
tion  receptors,  such  as  Toll-like  receptors  (TLRs), 
Nod-like receptors, and C-type lectins, expressed by 
these cells are important in distinguishing a diverse 
but  overlapping  repertoire  of  conserved  microbial 
molecules  (26).  DC  precursors  are  generated  from 
pluripotent stem cells in the bone marrow under the 
influence  of  lineage  specific  growth  factors  and  are 
released into the blood for transit to lymphoid organs, 
including  secondary  lymphoid  tissues  such  as  the 
spleen as well as non-lymphoid tissues such as the 
skin,  where they reside as immature cells (22). Fol-
lowing  encounter  with  antigen,  immature  DC  un-
dergo  maturation  in  response  to  stimulation  by 
pathogens or cytokines and other soluble mediators 
produced by various cell types. DC maturation results 
in a decreased ability to capture and process antigen 
and  increased  surface  expression  of  MHC-II  and 
co-stimulatory  (CD40,  CD80,  CD86)  and  adhesion 
molecules  (22-27).  DC  maturation  is  critical  in  im-
munity to pathogenic microorganisms because of the 
potent ability of these cells to polarize the differentia-
tion of naïve CD4+ T cells to Th cell subsets including 
Th1, Th2, Th17, follicular Th cells, and induced regu-
latory T cells (28,29). DC also function as accessory 
cells and are important in activating NK cells for cy-
totoxicity  and  cytokine  secretion  in  response  to  vi-
ruses and tumors (30). As a result of interactions with 
T cells, NK cells and other effector cells, the ability of 
DC to secrete cytokines is enhanced. DC, thus, are not 
only important in antigen presentation and activating 
CD4+  T  cells  but  also  function  as  accessory  cells  to 
regulate  and  amplify  innate  and  adaptive  immune 
responses. 
The  relationship  between  DC  maturation  and 
malaria  has  been  investigated  in  studies  using  pe-
ripheral blood monocytes from humans and murine 
DC (25,31). Initially, it was shown that DC function is 
compromised  during  malaria  based  on  the  in  vitro 
observation that binding of P. falciparum iRBC to hu-
man  monocyte-derived  DC  inhibits  maturation  and 
reduces the capacity of the DC to function as an APC 
(32). Analysis of DC recovered from African children 
with  severe  P.  falciparum  malaria  revealed  that  the 
frequency of myeloid-derived CD11c+BDCA3+ DC is 
significantly increased during acute infection (33). A 
recent study comparing DC subpopulations in indi-
viduals infected with P. falciparum or P. vivax and re-
siding in areas with similar endemicity found a sig-
nificant  increase  in  plasmacytoid  CD123+ DC  and  a 
decreased ratio of myeloid to plasmacytoid DC dur-
ing infection, regardless of the infecting species (34). 
In this study, the maturation of peripheral blood DC 
was observed to be impaired ex vivo as shown by low 
CD86  expression  in  a  proportion  of  the  P.  vi-
vax-infected patients, but there was no evidence that 
DC maturation was affected in P. falciparum-infected 
individuals. These data suggest that DC subpopula-
tions  are  differentially  affected  in  humans  during 
blood-stage malaria and that the variability observed 
in the effects of malaria infection on DC function may 
be due to the Plasmodium species, the severity of the 
infection, and the patient population studied. 
Similar observations of diverse effects of malaria 
infection  on  DC  have  been  made  in  studies  using 
various combinations of parasites and inbred mouse 
strains. Distinct subpopulations of DC including my-
eloid-derived  DC  (CD11c+CD4+,  CD11c+CD8+, 
CD11c+CD8-), plasmacytoid DC (CD11c+B220+), and 
a regulatory subset of CD11clowCD45RBhigh DC have 
been observed to expand in the spleens of mice in-
fected with various Plasmodium parasites (27,31,35-38). Int. J. Biol. Sci. 2011, 7 
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The development of transgenic mice expressing a T 
cell  receptor  (TCR)  specific  for  a  peptide  of  the  P. 
chabaudi merozoite surface protein-1 (MSP1) has pro-
vided  a  novel  tool  to  elucidate  the  role  of  DC  and 
other cells in the immune response to malaria (39). 
Using  transgenic  MSP1-specific  TCR  mice  infected 
with P. chabaudi AS, Sponaas et al provided direct ev-
idence that CD11c+ DC in the spleen activate Plasmo-
dium-specific CD4+ T cells (38). This study also pro-
vided evidence that splenic DC subpopulations have 
distinct antigen presenting functions during malaria. 
Although  both  CD8+  and  CD8-  DC  present  malaria 
peptides  and  induce  IFN-  production  by  CD4+  T 
cells, only CD8- DC stimulate antigen-specific prolif-
eration of CD4+ T cells and secretion of IL-4 and IL-10.  
Recently, Lundie et al reported another strategy 
to  study  the  immune  response  to  malaria  that  in-
volves the generation of genetically-modified strains 
of  P.  berghei  ANKA  expressing  MHC-I-  and 
MHC-II-restricted T cell epitopes specific for cognate 
antigens, such as OVA, linked to reporter GFP (40). 
Using the genetically modified parasites to infect OT-I 
or OT-II transgenic mice, these investigators observed 
that both CD8-CD4+ and CD8+ but not CD8-CD4- 
DC present P. berghei-expressed antigens to CD4+ T 
cells during malaria infection, while the CD8+ sub-
population  induces  pathogenic  CD8+  T  cells  via 
cross-presentation  (40).  In  a  separate  study, 
blood-stage P. berghei ANKA infection was found to 
cause  suppression  of  MHC-I-restricted  immunity  to 
non-malarial  antigens  as  a  possible  consequence  of 
systemic DC activation (41). This observation suggests 
that DC are not directly suppressed by malaria para-
sites,  but  that  they  follow  their  normal  maturation 
pathway  after  activation  by  iRBC  or  parasite  prod-
ucts. Subsequent findings by Lundie et al showed that 
DC isolated from  P. berghei-infected mice efficiently 
present  P.  berghei-expressed  antigens  to  CD4+  and 
CD8+ T cells on days 2 and 3 p.i., but their ability to 
present  parasite  antigens  as  well  as  MHC-I-  and 
MHC-II-restricted, non-malarial antigens is drastical-
ly impaired by day 4 p.i. (42). These findings are con-
sistent  with  earlier  studies  by  Perry  et  al  in  P. 
yoelii-infected  mice  which  showed  that  DC  become 
refractory to TLR-ligand-stimulated IL-12 and TNF- 
production with increased IL-10 secretion as the in-
fection progresses (43). DC from infected mice were 
found to retain the capacity to stimulate OVA-specific 
proliferation of naïve OT-II CD4+ T cells throughout 
P. yoelii infection, but the responding T cell phenotype 
changed  later  during  infection  from  CD4+IFN-+  to 
CD4+IL-10+ T cells. However, functional impairment 
of DC at early times p.i. during lethal infections due to 
P. yoelii YM, P. vinckei or P. berghei ANKA has been 
observed based on the inability of DC from infected 
mice to secrete high levels of IL-12 and prime naïve 
CD4+ T cells (31). It was reported that the decreased 
function of DC in mice infected with P. vinckei or P. 
berghei is mediated in part by TNF- (31). In contrast, 
Lundie and colleagues failed to demonstrate a role for 
TNF-  in  impaired  DC  function  during  P.  berghei 
ANKA  infection  (42).  As  will  be  described  below, 
spleen DC recovered from P. chabaudi AS-infected B6 
mice  during  the  first  week  p.i.  are  fully  functional 
APC  (31,44).  Altogether,  studies  in  mouse  models 
essentially confirm the findings in human studies and 
provide further explanation that the conflicting data 
obtained  in  human  studies  may  be  due  to  several 
factors including the parasite species and strain, the 
time after infection, and the size of the inoculum. 
Role of DC as accessory cells 
Studies  performed  using  human  peripheral 
blood mononuclear cells and in Plasmodium-infected 
mice indicate that NK cells are an early and crucial 
source  of  IFN-  during  blood-stage  malaria  (12). 
Findings  in  experimental  models  of  infection,  espe-
cially viral infections, tumors, and inflammatory dis-
eases, provide important evidence that optimal IFN- 
production  by  NK  cells  requires  contact-dependent 
and -independent interactions with myeloid-derived 
accessory cells such as monocytes, macrophages, and 
DC (30). As will be described below, we investigated 
if an accessory cell is necessary to promote IFN- se-
cretion  by  NK  cells  during  P. chabaudi  AS  infection 
and questioned if CD11c+ DC are involved.  
Previous studies in B6 mice showed that during 
early P. chabaudi AS infection DC, macrophages, and 
NK cells rapidly accumulate and expand in the spleen 
where they undergo maturation and functional acti-
vation in response to iRBC captured in the spleen by 
phagocytosis (reviewed in 44). During early infection, 
CD11c+  DC  migrate  from  the  marginal  zone  to  the 
CD4+  T  cell-rich  periarteriolar  lymphoid  sheaths 
while  macrophages  expand  and  remain  in  the  red 
pulp  (45).  Importantly,  within  the  first  week  p.i., 
spleen DC from P. chabaudi AS-infected B6 mice dis-
play  up-regulation  of  MHC-II  and  co-stimulatory 
molecule expression, secrete pro-inflammatory cyto-
kines  including  high  levels  of  IL-12,  and  stimulate 
naïve CD4+ T cell proliferation and IFN- production 
(25,27,31,45). In contrast, splenic macrophages from P. 
chabaudi AS-infected mice suppress T cell proliferation 
and  IL-2  secretion  (46,47).  Together,  these  findings 
provide compelling evidence that CD11c+ DC play an 
important role in innate immunity during blood-stage 
malaria and trigger an adaptive type 1 immune re-Int. J. Biol. Sci. 2011, 7 
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sponse necessary for control and rapid resolution of 
infection. 
To determine if DC have a role in activating NK 
cells  during  blood-stage  malaria,  we  compared  the 
maturation  and  function  of  CD11c+  DC  purified  by 
magnetic beads from the spleens of infected wild-type 
(WT) B6 mice and IL-12p40-/- and IL-15-/- mice that 
lack cytokines involved in NK cell proliferation, sur-
vival  and  activation  (44).  In  previous  studies,  we 
demonstrated that the course of P. chabaudi AS infec-
tion is more severe in IL-12p40-/- mice compared to 
WT  and  IL-15-/-  mice  (12,  reviewed  in  44).  We  ob-
served that the uptake of iRBC by CD11c+ DC early 
after  infection  was  similar  in  WT,  IL-12p40-/-,  and 
IL-15-/- mice. DC from infected IL-15-/- and WT mice 
expressed  similar  levels  of  CD40,  CD80,  and  CD86 
while  DC  from  infected  IL-12p40  -/- mice  expressed 
significantly lower levels of co-stimulatory molecules. 
Analysis of cytokine production in response to in vitro 
stimulation  with  iRBC  revealed  that  DC  recovered 
from IL-12p40-/- mice on day 4 p.i. produced signifi-
cantly  lower  levels  of  pro-inflammatory  cytokines 
compared to WT DC but secreted significantly more 
IL-2  while  the  levels  of  IL-10  secreted  by  WT, 
IL-12p40-/-, and IL-15-/- DC were similar. These data 
indicate  that  CD11c+  DC  from  infected  IL-12p40-/- 
mice  are  as  efficient  as  DC  from  infected  WT  and 
IL-15-/- mice in phagocytizing iRBC but that DC mat-
uration is impaired in infected IL-12p40-/- mice. 
To investigate if DC from P. chabaudi AS-infected 
mice promote IFN- production by NK cells, we es-
tablished  co-cultures  of  purified  CD11c+  DC  from 
infected WT mice with CD3-DX5+ NK cells purified 
from the spleens of naïve WT mice and analyzed NK 
cell expression of intracellular IFN- expression before 
and after co-culture with DC by flow cytometry (44). 
IFN-  levels  in  the  supernatants  of  the  co-cultures 
were  also  determined.  As  shown  in  Fig.  1A,  few 
CD3-DX5+  NK  cells  from  naïve  WT  mice  expressed 
intracellular IFN- prior to co-culture with DC from 
infected WT mice. After co-culture with DC from in-
fected mice, there was a dramatic increase in the fre-
quency  of  DX5+IFN-+  NK  cells.  Although  the  fre-
quency  of  CD11c+IFN-+  DC  also  increased  in  the 
co-cultures, the major source of IFN-was observed to 
be NK cells, a finding corroborated when DC from 
infected  WT  mice  were  co-cultured  with  NK  cells 
from  naïve  IFN--/-  mice  (44).  Determination  of  the 
levels of IFN- in the supernatants confirmed that WT 
DC from infected mice stimulated significantly higher 
IFN- secretion than WT DC from naïve mice (Fig. 1B).  
 
 
Figure 1. DC from infected mice activate NK cells to produce IFN-. CD11c
+ DC enriched by magnetic beads from the 
spleens of P. chabaudi AS infected B6 mice on day 5 p. i. and NK cells (CD3
-DX5
+) enriched by magnetic beads from the 
spleens of naïve B6 mice were cultured separately or co-cultured together for 24-36 hrs. (A) The expression of intracellular 
IFN- was analyzed by flow cytometry in gated CD11c
+DX5
- and CD3
-DX5
+ cells before co-culture (Pre-culture, left panel) 
and after culture separately (solid lines) or together in co-cultures (shaded areas) (Post-culture, right panel). (B) IFN- levels 
in the supernatants of NK cells or DC from day 5 infected mice cultured separately or of co-cultures of NK cells and DC 
from mice at day 0 or 5 p.i. were determined by ELISA. Transwell indicates that DC and NK cells were separated using a 
transwell insert. ***, p<0.001 indicates significant differences compared to DC from day 5 infected B6 mice. Originally 
published in part in Infection and Immunity (Ref. 44), Copyright® 2009, The American Society for Microbiology. Int. J. Biol. Sci. 2011, 7 
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Figure 2. IL-12 secretion by DC is required for optimal NK cell IFN- production during blood-stage malaria. CD11c
+ DC 
enriched by magnetic beads from the spleen of P. chabaudi AS-infected WT B6 and IL-12p40
-/- mice were co-cultured with 
NK cells enriched by magnetic beads from the spleens of naïve WT or IL-12p40
-/- mice. (A) The expression of intracellular 
IFN- was analyzed by flow cytometry in gated CD11c
+DX5
- and CD3
-DX5
+ cells in co-cultures of DC from infected WT or 
IL-12p40
-/- mice and NK cells from naïve WT (left panel) or IL-12p40
-/- (right panel) mice. (B) IFN- levels in the supernatants 
of co-cultures of DC from infected WT or IL-12p40
-/- mice and NK cells from naïve WT or IL-12p40
-/- mice were deter-
mined by ELISA. ***, p<0.001 indicates significant differences compared to co-cultures of DC from infected WT mice and 
NK cells from naïve WT mice. Originally published in part in Infection and Immunity (Ref. 44), Copyright® 2009, The 
American Society for Microbiology. 
 
We also determined the relative contribution of 
IL-12  and  IL-15  to  DC-NK  cell  interactions  during 
malaria  by  co-culturing  purified  CD11c+  DC  from 
infected IL-12p40-/- or IL-15-/- mice with NK cells from 
naïve WT mice. DC from infected IL-15-/- mice stim-
ulated a similar percentage of WT NK cells to express 
intracellular IFN- as WT DC, and IFN- levels were 
similar  in  supernatants  of  WT  NK  cells  co-cultured 
with WT DC and IL-15-/- DC. In contrast, DC from 
infected IL-12p40-/- mice are unable to promote IFN- 
expression by NK cells from naïve WT mice (Fig. 2A 
and 2B). These data are consistent with the observa-
tions described above linking lethal malaria infections 
in mice with functional impairment of DC and indi-
cate that soluble mediators, especially IL-12, are re-
quired to induce optimal IFN- secretion by NK cells 
during  blood-stage  malaria.  We  also  observed  that 
DC-NK cell interaction is dependent on cell-cell con-
tact  since  significantly  lower  IFN-  production  was 
observed when NK cells and DC were separated by a 
transwell insert. 
Reciprocal crosstalk between DC and NK cells 
has been demonstrated in a number of studies, with 
evidence of complex interactions between the two cell 
types (30,48). NK cells activated by tumors, bacterial 
products,  or  IL-2  have  been  shown  to  induce  DC 
maturation and secretion of the Th1-promoting cyto-
kine IL-12 (30,48). To determine if malaria-activated 
NK cells induce DC maturation, we co-cultured puri-
fied DX5+ NK cells from day 5 infected WT mice with 
CD11c+ DC from naïve WT mice which were exposed 
to iRBC for 1 hr prior to co-culture with NK cells to 
prevent  lysis  of  immature  DC  by  the  activated  NK 
cells (44). DC from naïve mice co-cultured with NK 
cells  from  infected  WT  mice  displayed  significantly 
increased  CD40  and  CD86  expression  compared  to 
control DC cultured alone or with NK cells from naïve 
WT  mice  (Fig.  3A).  Up-regulation  of  co-stimulatory 
molecule expression on DC co-cultured with malar-
ia-activated NK cells was found to be dependent on 
cell  contact.  Co-culture  with  malaria-activated  NK 
cells but not NK cells from naïve mice also stimulated 
DC to secrete high levels of cytokines especially IL-12 
(Fig. 3B). DC separated from NK cells by a transwell 
insert showed similar levels of cytokine production as 
control  co-cultures  indicating  that  soluble  factors 
produced  by  NK  cells  and  not  cell-cell  contact  are 
responsible  for  enhanced  IL-12  production  by  DC. 
The importance of NK cell-derived IFN- in inducing 
enhanced production of Th1-promoting IL-12 by DC Int. J. Biol. Sci. 2011, 7 
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was demonstrated by co-culture of WT DC with NK 
cells from P. chabaudi AS-infected IFN--/- mice and by 
the  addition  of  anti-IFN-  monoclonal  antibody  to 
co-cultures of WT DC and WT NK cells. In the ab-
sence of NK cell-derived IFN-, DC produced signifi-
cantly  higher  levels  of  the  immunoregulatory  cyto-
kine  IL-10.  Importantly,  DC  stimulated  by  malar-
ia-activated NK cells were found to be fully licensed 
APC and primed naïve CD4+ T cells to proliferate and 
produce the type 1 cytokine IFN- indicating Th1 po-
larization (44). 
 
Figure 3. Malaria-activated NK cells stimulate DC to mature and secrete cytokines. NK cells enriched by magnetic beads 
from the spleens of day 5 P. chabaudi AS-infected B6 mice were co-cultured with CD11c
+ DC enriched by magnetic beads 
from the spleens of naïve B6 mice. DC were exposed to iRBC prior to co-culture to limit the cytotoxic effects of NK cells. 
DC were analyzed for co-stimulatory molecule expression and cytokine production. To determine the role of NK secreted 
IFN-, DC were co-cultured with NK cells from IFN-
-/- mice or with WT NK cells in the presence of anti-IFN- monoclonal 
antibody or isotype control antibody (data not shown). DC were also co-cultured with NK cells in wells with a transwell 
insert to prevent cell-cell contact. Panel A shows the strategy to determine the mean fluorescence intensity (MFI) of CD40, 
CD80 and CD86. Histogram in dotted line represents isotype control, grey line, DC co-cultured with day 0 NK, black line, 
DC co-cultured with day 5 NK. Panel B shows the CD40, CD80 and CD86 expression (MFI) after culture alone or 
co-culture with NK cells from naïve mice (Day 0 NK) as controls or co-culture with WT or IFN-
-/- NK cells from day 5 
infected mice (Day 5 NK). The asterisks indicate a significant difference between DC separated from day 5 NK cells by a 
transwell insert (Transwell) or DCs co-cultured with day 5 NK cells (Coculture); **, p <0.01. (C) Cytokine levels in su-
pernatants of DC cultured alone or with day 0 or day 5 NK cells were determined by ELISA. The data are representative of 
three experiments, each containing three or four replicates per group. The asterisks indicate significant differences between 
WT NK cells (coculture) and IFN-
-/- cells; **, p <0.01 and ***, p <0.001. The error bars indicate SEM. Originally published 
in part in Infection and Immunity (Ref. 44), Copyright® 2009, The American Society for Microbiology. Int. J. Biol. Sci. 2011, 7 
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Our  observations  in  the  mouse  model  of  P. 
chabaudi  AS  infection  confirmed  in  vitro  studies  by 
Newman  et al in  human  peripheral  blood  mononu-
clear cells stimulated with P. falciparum iRBC showing 
that  IFN-  production  by  NK  cells  only  occurs  fol-
lowing  multiple  contact-dependent  and  cyto-
kine-mediated signals derived from myeloid-derived 
DC and monocytes (49). Importantly, reciprocal acti-
vation  of  accessory  cell  maturation  by  malar-
ia-activated NK cells was observed in the studies with 
PBMC and in our studies in mice. These findings in-
dicate  that  interactions  between  accessory  cells  and 
NK cells during malaria are bi-directional similar to 
virus and tumor models (30,44,48,49). To address if 
NK cells are required to induce DC maturation and 
function  in vivo,  we  treated  P. chabaudi  AS-infected 
WT mice with anti-asialo-GM1 antibody and exam-
ined DC maturation and Th cell polarization. As we 
observed  previously,  infected  B6  mice  treated  with 
anti-asialo-GM1  antibody  mice  display  a  course  of 
infection characterized by a significantly higher peak 
parasitemia  and  significantly  higher  recrudescent 
parasitemia  during  the  chronic  phase  of  infection 
(12,44). It should be noted that a similar course of P. 
chabaudi  AS  infection  is  also  evident  in  IL-12p40-/- 
mice which are deficient in NK cell secretion of IFN- 
during early infection (50). During infection, CD11c+ 
DC purified from the spleens of NK cell-depleted WT 
mice expressed lower levels of CD40 and CD86 and 
produced  significantly  less  IL-12  and  more  IL-2  in 
response to iRBC in vitro than DC from isotype con-
trol-treated WT mice. Impairment of DC maturation 
and IL-12 production in infected NK cell-depleted WT 
mice resulted in inefficient priming of naïve CD4+ T 
cells  for  malaria  antigen-specific  proliferation  and 
IFN-  secretion  compared  to  DC  from  isotype  con-
trol-treated WT mice. Together, these data provide in 
vivo evidence that DC-NK cell crosstalk is required for 
DC maturation and function and optimal IFN- pro-
duction  by  NK  cells  and  CD4+  T  cells  during  P. 
chabaudi AS infection. 
Natural CD4+Foxp3+ regulatory T cells and 
blood-stage malaria 
Recent studies have focused on the role of CD4+ 
regulatory T cells in regulating adaptive immune re-
sponses  during  Plasmodium  infection.  In  particular, 
natural  CD4+Foxp3+  regulatory  T  cells  have  been 
shown to be important in determining the outcome of 
infection  with  various  intracellular  pathogens,  in-
cluding  protozoan  parasites  (51,52).  CD4+Foxp3+  T 
cells  have  been  shown  to  inhibit  effector  T  cell  re-
sponses  during  infection,  resulting  in  inadequate 
immune control of the pathogen and persistence  of 
low-level infection. It has also been observed that the 
potent ability of natural regulatory T cells to modulate 
effector T cell responses is important in limiting the 
development of tissue damage during infection with 
protozoan parasites (51,52). 
Studies in individuals with malaria and in mice 
infected with various rodent Plasmodium species have 
revealed  an  important  expansion  of 
CD4+CD25+Foxp3+  T  cells  (53-55).  Experimental  P. 
falciparum infection in human volunteers showed that 
the magnitude of expansion of this T cell population 
correlates  with  high  parasitemia  levels  and  low 
pro-inflammatory responses, findings that suggest a 
possible link between natural regulatory T cells and 
the clinical outcome of malaria (53). Experiments to 
determine the impact of CD4+CD25+Foxp3+ T cells in 
Plasmodium-infected mice by depleting CD25+ T cells 
have  led  to  inconsistent  findings  (53-55).  Although 
there are several possible explanations for the incon-
sistencies, including the concern that antibody deple-
tion of CD25+ T cells may result in the loss of naïve 
and  effector  T  cells,  the  results  of  these  studies  are 
consistent with the notion that natural regulatory T 
cells suppress pro-inflammatory responses involved 
in protective immunity as well as immunopathology 
during malaria (53-55). 
We investigated the role of CD4+Foxp3+ regula-
tory T cells during P. chabaudi AS infection using sev-
eral approaches as alternatives to in vivo depletion of 
CD25+ T cells (56). First, we compared the course and 
outcome  of  P.  chabaudi  AS  infection  and  malar-
ia-specific immune responses in WT mice and trans-
genic mice generated by Khattri et al (57) that over-
express the  Foxp3 transcription factor. Compared to 
infected  WT  mice,  infected  Foxp3  transgenic  mice 
develop fulminant peak parasitemia levels and 100% 
of these mice succumb to the infection in association 
with  deficient  malaria-specific  immune  responses. 
Adoptive  transfer  of  regulatory  T  cell  populations 
purified from Foxp3 transgenic or WT mice to recip-
ient WT mice confirmed that high numbers of these 
cells compromised immune control of malaria.  
It is well established that an intact spleen is re-
quired  for  the  development  of  protective  immune 
responses to malaria infection in mice (58). To deter-
mine if regulatory T cells localize to this tissue during 
P.  chabaudi  AS  infection,  we  adoptively  transferred 
CD4+CD25+ or CD4+CD25- T cells purified from the 
spleens of UBI-GFP/B6 reporter mice and analyzed 
the frequency of CD4+GFP+ T cells in various tissues 
in recipient WT mice infected with P. chabaudi AS one 
day  later.  This  experiment  demonstrated  that 
GFP+CD4+  T  cells  preferentially  accumulate  in  the 
spleen  as  opposed  to  the  blood  or  draining  lymph Int. J. Biol. Sci. 2011, 7 
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nodes (56). We also observed that significantly higher 
numbers  of  GFP+CD4+CD25+  compared  to 
GFP+CD4+CD25- T cells accumulate in the spleens of 
infected recipient mice. Immunohistochemical stain-
ing  of  spleen  sections  from  infected  WT  mice  con-
firmed that Foxp3+ regulatory T cells accumulate in 
the spleen during malaria and demonstrated that this 
T cell population localizes almost exclusively within 
the T cell areas of the white pulp. 
Additionally,  we  investigated  if 
CD4+CD25+Foxp3+ T cells expand in the spleen of WT 
mice during P. chabaudi AS infection by analyzing the 
frequency of regulatory T cells at various times p.i. by 
flow  cytometry.  Consistent  with  previous  observa-
tions, we observed a significant but transient increase 
in  the  numbers  of  CD4+CD25+Foxp3+ T  cells  in  the 
spleen of infected WT mice, which was followed by a 
significant  and  sustained  decrease  due  to  reduced 
proliferation and apoptosis of CD4+Foxp3+ T cells (56). 
The T cell growth factor IL-2, a cytokine produced by 
activated CD4+ T cells, is required for the expansion, 
survival,  and  function  of  natural  regulatory  T  cells 
and especially to maintain Foxp3 expression by these 
cells (59). Decreases in IL-2 secretion by effector CD4+ 
T cells has been shown to be important for contraction 
of  Foxp3+  regulatory  T  cells  in  mice  infected  with 
Toxoplasma gondii (52). During P. chabaudi AS infection 
in WT mice, we observed that the kinetics of IL-2 se-
cretion by effector CD4+Foxp3- T cells coincided with 
changes in CD4+Foxp3+ cells and the differentiation of 
CD4+T-bet+IFN-+ cells required for immune control 
of blood-stage malaria. As shown in Fig. 4B, the ad-
ministration of an immune complex consisting of re-
combinant murine IL-2 and anti-IL-2 monoclonal an-
tibody (clones JES6-1) to infected WT mice increased 
the severity of P. chabaudi AS infection and promoted 
the expansion of Foxp3+ regulatory T cells (56,60).  
 
Figure 4. Treatment with IL-2/anti-IL-2 complex increases the severity of P. chabaudi AS infection by promoting the ex-
pansion of CD4
+Foxp3
+ regulatory T cells. Infected B6 mice were treated daily by intraperitoneal injection for 3 days (days 
0 to 2 p.i.) with 200 l IL-2/JES6-1 monoclonal antibody (1:10) complex, isotype control antibody or PBS. (A) Course of 
parasitemia in treated and control mice. Spleen cells recovered from naïve B6 mice and the three groups of infected mice 
were analyzed for expression of CD25 and intracellulear Foxp3 in gated CD4
+ cells by FACS. Representative dot plots of the 
(B) frequency of CD4
+CD25
+Foxp3
+ cells in PBS-treated and IL-2/antiIL-2 complex-treated mice on days 7 and 9 p.i., and the 
(C) frequency and (D) number of Foxp3
+CD25
+ in gated CD4
+ cells in PBS control and complex-treated mice during in-
fection are shown. Data are expressed as mean ± SEM of 5 mice per group from one of two replicate experiments. ***, p 
<0.001, complex-treated compared to control mice. Originally published in The Journal of Immunology (Ref. 56), Copy-
right®2011, The American Association of Immunologists, Inc. Int. J. Biol. Sci. 2011, 7 
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Together, our findings demonstrate that a tight 
balance between CD4+Foxp3+ regulatory T cells and 
effector  CD4+  Th1  cells  is  necessary  to  effectively 
control and eliminate P. chabaudi AS infection and that 
this balance is dependent in part on IL-2. Although 
our findings provide convincing evidence that shift-
ing the balance between natural regulatory T cells and 
effector CD4+ T cells in favor of CD4+Foxp3+ T cells 
severely compromises immune control of blood-stage 
malaria, it has not been established if this balance is 
perturbed in individuals infected with P. falciparum in 
endemic areas (61). Nor has the contribution of IL-2 to 
expansion of CD4+Foxp3+ T cells in humans infected 
with malaria been investigated. 
Conclusions 
Studies  in  malaria-infected  humans  and  in 
mouse models provide strong evidence that Plasmo-
dium parasites modulate DC maturation and function 
and induce the expansion of CD4+Foxp3+ regulatory T 
cells. In turn, these regulatory T cells may modulate 
effector  CD4+  T  cell  responses  to  malaria  infection 
suppressing  protective  immune  responses  but  pre-
venting immune-mediated pathology. Accumulating 
data indicate that immune control of parasite growth 
is a likely down-stream effect of induction  of func-
tionally  mature  DC  that  produce  IL-12  and  induce 
IFN- production by NK cells and CD4+ Th1 cells (Fig. 
5). Recent studies also indicate that myeloid-derived 
CD11c+ DC induce CD4+ T cells to secrete IFN- and 
lead to the development of experimental CM in mice 
infected  with  P. berghei ANKA  suggesting  that  ma-
laria-activated  DC  are  also  involved  in  mediating 
pathology during malaria (62). More extensive studies 
are required to provide a clearer understanding of the 
role  of  DC  that  are  deficient  in  producing  the 
Th1-promoting cytokine IL-12 and result in a lethal 
infection. The possibility that such DC have a tolero-
genic phenotype and secrete cytokines such as IL-2, 
IL-10, and TGF- which may induce regulatory T cells 
requires further investigation. Indeed, it has been ob-
served  that  populations  of  tolerogenic  human  and 
murine DC induce or promote CD4+Foxp3+ regulato-
ry T cells via TGF-- and IL-2-dependent mechanisms 
(63-66).  Increased  knowledge  concerning  DC  and 
CD4+Foxp3+ regulatory T cells may provide strategies 
for devising novel immunotherapeutic approaches for 
manipulating  the  immune  response  to  malaria  and 
tilting the balance between protective and immuno-
pathogenic responses in favor of the host and preven-
tion of severe disease.  
 
 
Figure 5. Role of DC in inducing adaptive immune responses that mediate protection as well as pathology or regulatory T 
cells that prevent pathology but suppress protective immunity. An iRBC is shown interacting with an immature DC and the 
possible consequences on the adaptive immune response to malaria. Int. J. Biol. Sci. 2011, 7 
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